Table 1.

Clinicopathologic and treatment-related characteristics of patients with sarcomatoid mRCC

Characteristic(n = 8)
Age, y
 Mean60.0
 Range(42.7–78.2)
Gender (n)
 Male6
 Female2
Sites of metastasis (n)
 Bone4
 Lung4
 Brain3
 Liver4
Risk group (n)
 Good1
 Intermediate7
 Poor0
Treatment (n)
 First-line
  VEGF-TKI4
  mTOR0
  Immunotherapy0
  Chemotherapy1
  None3
 Second-line
  VEGF-TKI1
  mTOR1
  Immunotherapy0
  Chemotherapy1
  None5
 Third-line
  VEGF-TKI1
  mTOR0
  Immunotherapy0
  Chemotherapy0
  None7